Financials
- Market Capitalization 1.16 B
- Employee 260
- Founded 2014
- CEO N/A
- Website www.kuraoncology.com
- Headquarter Delaware, United States
- FIGI BBG008974342
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.26
Relación precio/flujo de caja
12.53
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2326 | CRVS Corvus Pharmaceuticals, Inc. - Common Stock | 14.48 USD | -1.16% | +2.19% | +2.84% | +151.83% | 1.22 B USD | ||
| 2339 | GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 14.10 USD | -1.95% | +2.99% | -13.23% | +24.78% | 1.20 B USD | ||
| 2366 | SANA Sana Biotechnology, Inc. - Common Stock | 3.88 USD | -1.02% | -2.27% | +12.79% | +30.64% | 1.16 B USD | ||
| 2392 | SLDB Solid Biosciences Inc. - Common Stock | 10.34 USD | -0.77% | +5.40% | +16.97% | +81.40% | 1.11 B USD |